So all this AVNE/MedScience trademark talk is pretty premature then? And if the relationship proves true, there's a series of hypotheticals that make the discussion marginally helpful to investors.
I'd personnaly like to know about the (potential) new business model and the players involved. If Berkeley Bio is involved, the future is bright!